UA103788U - Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
- Google Patents
Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Odesa Nat MedicalfiledCriticalUniv Odesa Nat Medical
Priority to UAU201507331UpriorityCriticalpatent/UA103788U/en
Publication of UA103788UpublicationCriticalpatent/UA103788U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The method for the treatment of acute coronary syndrome without ST-segment elevation in the patients with ischemic heart disease and metabolic syndrome following the percutaneous transluminar coronary angioplasty provides for the use of cardiocytoprotectors. Since the second day after percutaneous coronary intervention, Trimetazidin is prescribed as a supplement to the standard therapy, 35 mg twice a day with the meals, at least for 12 months.
UAU201507331U2015-07-212015-07-21Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
UA103788U
(en)
Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Method for treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following percutaneous transluminar coronary angioplasty
Treatment of acute coronary syndrome without st-segment elevation in patients with ischemic heart disease and metabolic syndrome following transcutaneous transluminar coronary angioplasty